New report charts path for Vietnam’s clinical trial growth
May 21, 2025 | 08:58
Pharma Group released the ‘Roadmap to the Future of Clinical Trials in Vietnam’ report on May 20 in Ho Chi Minh City.
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
January 03, 2025 | 00:43
Hanx Biopharmaceuticals, CO. Ltd, today announced the first patient dosing in Australia on Dec 30, 2024 for Phase 1 clinical trial of HX044 in patients with advanced solid tumors.
Mobile Version